Anne Wojcicki outlines AI research ambitions for 23andMe's next chapter
Sign in✓ Signed in
Anne Wojcicki says AI could help the 23andMe Research Institute turn consented genetic and health data into new medical insights as it rebuilds after bankruptcy. At the WTF Summit in Napa Valley, she pointed to a large-cohort lung cancer study as an example of what scale can uncover, alongside a separate Biohub effort assembling $1.8 billion in resources for AI-ready biology.
Continue reading
The rest of this article is for AI News Blitz readers. Choose an option below to keep reading.
Already purchased? Sign in✓ Signed in — this article isn’t included in your current plan.
Unlocking the full article...